Nevro Announces Acquisition of Vyrsa™ Technologies

Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain, announces that it has acquired Vyrsa Technologies (“Vyrsa”), a privately held medical technology company focused on a minimally invasive treatment option for patients suffering from chronic sacroiliac joint (“SI Joint”) pain. Under the terms of the transaction, which signed and closed on November 30, 2023, Nevro paid $40 million at closing and agreed to pay up to an additional $35 million in cash or stock tied to achievement of certain development and sales milestones.

Read the full article: Nevro Announces Acquisition of Vyrsa™ Technologies //


Leave a Comment

Your email address will not be published.

Scroll to Top